Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Gynecol Oncol. 2017 Dec 21;148(2):357–362. doi: 10.1016/j.ygyno.2017.12.014

Table 4.

Self-Reported Race/Ethnicity and a) HPV 16+ and b) and HPV 18+ Integration.

Fully/Partially Integrated
(n)
Not Integrated
(n)
OR (95% CI) aOR (95% CI)a
a) HPV 16 Integration
(n=396)

Self-Reported
Race/Ethnicity
 Non-Hispanic White 42 (17%) 207 (83%) Reference (1.00) Reference (1.00)
 Hispanic 17 (27%) 46 (73%) 1.82 (0.95–3.48) 1.93 (0.96–3.89)
 Non-Hispanic Black 15 (33%) 31 (67%) 2.38 (1.18–4.80) 2.78 (1.29–5.98)
 Non-Hispanic Asian 3 (10%) 26 (90%) 0.57 (0.16–1.97)
 Non-Hispanic Other 0 (0%) 9 (100%) ***

b) HPV 18 Integration
(n=180)

Self-Reported
Race/Ethnicity
 Non-Hispanic White 46 (43%) 62 (57%) Reference (1.00) Reference (1.00)
 Hispanic 14 (47%) 16 (53%) 1.18 (0.52–2.66) 1.01 (0.42–2.46)
 Non-Hispanic Black 13 (42%) 18 (58%) 0.97 (0.43–2.19) 1.12 (0.43–2.91)
 Non-Hispanic Asian 4 (57%) 3 (43%) 1.80 (0.38–8.42)
 Non-Hispanic Other 2 (50%) 2 (50%) 1.35 (0.18–9.93)
a

aOR adjusted for age (continuous); age of sexual debut (continuous); number of lifetime sexual partners (reference = 5–9); history of tobacco use (reference = no).

***

Not able to calculate due to sample size.

— Adjusted estimate not shown due to cell counts less than five.